Privilege escalation in Gbgplc Acuant Acufill Sdk

CVE-2022-48226

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.

Vulnerability class: Privilege Escalation

Published · last modified .

CVSS v3 metric

CVSS v3 base score 7.8 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.002 (7.0th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 7th percentile — 7.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2022-48226: held from 0.002 to 0.002.

EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2022-48226?
CVE-2022-48226 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk, classified under Improper Privilege Management. CVSS score: 7.8/10. Published 2023-04-04.
How severe is CVE-2022-48226?
High severity. CVSS v3 base score is 7.8 out of 10.